• ___
  • Svenska
  • Career
  • Contact
  • Facebook
  • Twitter
  • Linkedin
  • About IRLAB
    • About IRLAB
    • Management
    • Board of directors
  • Therapeutic focus
    • Therapeutic focus
    • Parkinson’s disease
      • Patient portrait
    • PD-LIDs
    • PD-Falls
  • Project portfolio
    • Project portfolio
    • Mesdopetam (IRL790)
    • Pirepemat (IRL752)
    • IRL942
    • IRL757
    • IRL1117
    • Discovery phase
  • Research platform
    • ISP platform
    • Scientific publications
  • Newsroom
    • Newsroom
    • Press releases
    • Image library
  • Investors
    • Investors
    • Capital Markets Day 2023
    • Financial reports
    • Presentations & events
    • The share
      • Owners
      • Share capital development
      • PDMR transactions
      • Analysts
    • Financial calendar
    • CMD 2022
    • Listing Nasdaq Stockholm Main Market 2020
    • Rights issue Feb 2020
    • Initial public offering 2017
    • IR contacts
  • Corporate Governance
    • Corporate Governance
    • General Meetings
      • Annual General Meeting 2025
      • Previous general meetings
    • Corporate governance reports
    • Nomination committee
      • Nomination Committee for the AGM 2025
      • Previous nomination committees
    • Auditor
    • Remuneration
    • Internal control
    • Diversity
    • Articles of association
Hem>Newsroom>Image library
  • Newsroom
    • Newsroom
    • Press releases
    • Image library

Image library

Kristina Torfgård, CEODownload
Kristina Torfgård, CEOLadda ner
Nicholas Waters EVP, Head of R&DDownload
Viktor Siewertz CFODownload
Joakim Tedroff CMODownload
Carola Lemne, Chair of the BoardDownload
The ISP plattform in useDownload
Depicting work at IRLABDownload

SUBSCRIBE

IRLAB THERAPEUTICS AB
ARVID WALLGRENS BACKE 20
413 46 GÖTEBORG, SVERIGE

info@irlab.se
+46(0)31 757 38 00

youtube-filled